IKBKB and type 2 diabetes mellitus: Meanwhile, mesenchymal stem cells (MSCs) derived from patients with type-2 diabetes mellitus (T2DM) and atherosclerosis were used to investigate the effect of IKKB modulation on immuno-potency of MSCs [57].